From: MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer
Univariate | Multivariate | |||
---|---|---|---|---|
Variables | P | P | Exp (B) | 95 % CI for Exp (B) |
Gender | 0.96 | |||
Age | 0.79 | |||
Histopathologic types | 0.07 | |||
Smoking status | 0.27 | |||
Neoadjuvant treatment | 0.62 | |||
Tumor diameter | 0.008 | 0.86 | 1.04 | 0.66–1.66 |
Differentiation | 0.008 | 0.03 | 1.52 | 1.04–2.22 |
Local advance | 0.001 | 0.03 | 2.02 | 1.08–3.80 |
Lymph node metastasis | 0.001 | 0.98 | 1.01 | 0.46–2.22 |
Clinical stage | 0.001 | 0.84 | 0.92 | 0.42–2.02 |
MTA1 | 0.001 | 0.001 | 4.96 | 2.40–10.25 |
EpCAM | 0.001 | 0.045 | 1.92 | 1.02–3.64 |